Showing results (81-90 of 448) with videos related to

Sort By:
Pageof 45
Respiratory Medicine|August 6, 2026
COPD case finding and identification of at-risk individuals: opportunities for early personalized intervention and disease interceptionAlberto Papi, MeiLan K Han, Paola Rogliani, et al.
International Journal of Molecular Sciences|July 14, 2023
Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with SarcoidosisElisabetta Cocconcelli, Nicol Bernardinello, Gioele Castelli, et al.
Current Medical Research and Opinion|January 8, 2019
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbationAndrea Vianello, Beatrice Molena, Cristian Turato, et al.
The Journal of Allergy and Clinical Immunology|June 15, 2007
Chymase-positive mast cells play a role in the vascular component of airway remodeling in asthmaAndrea Zanini, Alfredo Chetta, Marina Saetta, et al.
Journal of Occupational Medicine and Toxicology (London, England)|March 5, 2008
New drugs targeting Th2 lymphocytes in asthmaGaetano Caramori, David Groneberg, Kazuhiro Ito, et al.
The International Journal of Biochemistry & Cell Biology|October 19, 2010
Mechanisms involved in lung cancer development in COPDGaetano Caramori, Paolo Casolari, Giorgio Narciso Cavallesco, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 14, 2008
Pathophysiology of viral-induced exacerbations of COPDAlfredo Potena, Gaetano Caramori, Paolo Casolari, et al.
Current Opinion in Pharmacology|May 4, 2007
Models of infection and exacerbations in COPDAlberto Papi, Marco Contoli, Gaetano Caramori, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|September 18, 2020
Treatment strategies for asthma: reshaping the concept of asthma managementAlberto Papi, Francesco Blasi, Giorgio Walter Canonica, et al.
Clinical Drug Investigation|February 23, 2012
Cost-effectiveness and cost-utility of beclomethasone/formoterol versus fluticasone propionate/salmeterol in patients with moderate to severe asthmaSimone Gerzeli, Carla Rognoni, Silvana Quaglini, et al.
Pageof 45